Ocular Therapeutix IncNASDAQ:OCUL
- LAST PRICE5.6400
- TODAY'S CHANGE (%)-0.0200 (-0.3534%)
- Bid / Lots5.5400/ 1
- Ask / Lots5.9000/ 1
- Open / Previous Close5.6800 / 5.6600
- Day Range
- 52 Week Range
- Volume2,314,768
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | OCUL |
|---|---|---|
| 09:32 ET | 16947 | 5.6808 |
| 09:34 ET | 6600 | 5.83 |
| 09:36 ET | 58051 | 5.804 |
| 09:38 ET | 1500 | 5.78 |
| 09:39 ET | 13306 | 5.75 |
| 09:41 ET | 2445 | 5.79 |
| 09:43 ET | 11243 | 5.775 |
| 09:45 ET | 800 | 5.76 |
| 09:48 ET | 995 | 5.76 |
| 09:50 ET | 4905 | 5.75 |
| 09:52 ET | 1054 | 5.7801 |
| 09:54 ET | 27029 | 5.83 |
| 09:56 ET | 152741 | 5.85 |
| 09:57 ET | 102364 | 5.8482 |
| 09:59 ET | 1000 | 5.86 |
| 10:01 ET | 3117 | 5.81 |
| 10:03 ET | 3251 | 5.81 |
| 10:06 ET | 200 | 5.815 |
| 10:08 ET | 7186 | 5.825 |
| 10:10 ET | 833 | 5.85 |
| 10:12 ET | 1395 | 5.8599 |
| 10:14 ET | 1753 | 5.83 |
| 10:15 ET | 2071 | 5.835 |
| 10:17 ET | 300 | 5.85 |
| 10:19 ET | 1672 | 5.835 |
| 10:21 ET | 3019 | 5.82 |
| 10:24 ET | 1400 | 5.81 |
| 10:26 ET | 100 | 5.81 |
| 10:28 ET | 800 | 5.8 |
| 10:30 ET | 1600 | 5.79 |
| 10:32 ET | 3808 | 5.8 |
| 10:33 ET | 1489 | 5.7925 |
| 10:35 ET | 3045 | 5.79 |
| 10:37 ET | 588 | 5.8 |
| 10:39 ET | 7115 | 5.85 |
| 10:42 ET | 1227 | 5.84 |
| 10:44 ET | 950 | 5.83 |
| 10:46 ET | 3050 | 5.8 |
| 10:48 ET | 1901 | 5.82 |
| 10:50 ET | 9250 | 5.85 |
| 10:51 ET | 1721 | 5.86 |
| 10:53 ET | 2500 | 5.845 |
| 10:55 ET | 6747 | 5.85 |
| 10:57 ET | 3610 | 5.85 |
| 11:00 ET | 7296 | 5.875 |
| 11:02 ET | 7101 | 5.885 |
| 11:04 ET | 12610 | 5.875 |
| 11:06 ET | 4233 | 5.88 |
| 11:08 ET | 81237 | 5.905 |
| 11:09 ET | 2456 | 5.89 |
| 11:11 ET | 2440 | 5.885 |
| 11:13 ET | 700 | 5.91 |
| 11:15 ET | 11514 | 5.895 |
| 11:18 ET | 2046 | 5.88 |
| 11:20 ET | 1468 | 5.885 |
| 11:22 ET | 3649 | 5.875 |
| 11:24 ET | 1100 | 5.88 |
| 11:26 ET | 4517 | 5.8733 |
| 11:27 ET | 2362 | 5.87 |
| 11:29 ET | 4584 | 5.86 |
| 11:31 ET | 1000 | 5.84 |
| 11:33 ET | 1202 | 5.86 |
| 11:36 ET | 7076 | 5.8507 |
| 11:38 ET | 600 | 5.865 |
| 11:40 ET | 3632 | 5.86 |
| 11:42 ET | 3416 | 5.845 |
| 11:44 ET | 2000 | 5.84 |
| 11:45 ET | 600 | 5.85 |
| 11:47 ET | 3872 | 5.84 |
| 11:49 ET | 1644 | 5.84 |
| 11:51 ET | 770 | 5.84 |
| 11:54 ET | 200 | 5.84 |
| 11:56 ET | 4366 | 5.84 |
| 11:58 ET | 1229 | 5.84 |
| 12:00 ET | 1813 | 5.855 |
| 12:02 ET | 2800 | 5.845 |
| 12:03 ET | 100 | 5.845 |
| 12:05 ET | 8514 | 5.83 |
| 12:07 ET | 2833 | 5.83 |
| 12:09 ET | 2595 | 5.83 |
| 12:12 ET | 500 | 5.8275 |
| 12:14 ET | 900 | 5.825 |
| 12:16 ET | 6206 | 5.815 |
| 12:20 ET | 20866 | 5.82 |
| 12:21 ET | 3648 | 5.83 |
| 12:23 ET | 6329 | 5.845 |
| 12:25 ET | 10390 | 5.8525 |
| 12:27 ET | 700 | 5.86 |
| 12:30 ET | 700 | 5.87 |
| 12:32 ET | 75913 | 5.81 |
| 12:34 ET | 2376 | 5.83 |
| 12:36 ET | 400 | 5.8267 |
| 12:38 ET | 3097 | 5.82 |
| 12:39 ET | 2915 | 5.8066 |
| 12:41 ET | 100 | 5.805 |
| 12:43 ET | 1100 | 5.81 |
| 12:45 ET | 7981 | 5.77 |
| 12:48 ET | 1405 | 5.78 |
| 12:50 ET | 4170 | 5.8 |
| 12:52 ET | 8205 | 5.8 |
| 12:54 ET | 14064 | 5.8 |
| 12:56 ET | 33382 | 5.81 |
| 12:57 ET | 3317 | 5.795 |
| 12:59 ET | 19784 | 5.74 |
| 01:01 ET | 2917 | 5.73 |
| 01:03 ET | 968 | 5.74 |
| 01:06 ET | 1176 | 5.74 |
| 01:08 ET | 6797 | 5.71 |
| 01:10 ET | 3192 | 5.71 |
| 01:12 ET | 4775 | 5.73 |
| 01:14 ET | 7123 | 5.73 |
| 01:15 ET | 2125 | 5.73 |
| 01:17 ET | 5409 | 5.7 |
| 01:19 ET | 3410 | 5.7 |
| 01:21 ET | 3937 | 5.72 |
| 01:24 ET | 2954 | 5.71 |
| 01:26 ET | 4960 | 5.73 |
| 01:28 ET | 8687 | 5.7 |
| 01:30 ET | 604 | 5.7 |
| 01:32 ET | 2476 | 5.7 |
| 01:33 ET | 11768 | 5.6625 |
| 01:35 ET | 10562 | 5.675 |
| 01:37 ET | 6596 | 5.68 |
| 01:39 ET | 7810 | 5.665 |
| 01:42 ET | 10535 | 5.645 |
| 01:44 ET | 7920 | 5.665 |
| 01:46 ET | 8297 | 5.64 |
| 01:48 ET | 2900 | 5.65 |
| 01:50 ET | 6483 | 5.65 |
| 01:51 ET | 4429 | 5.65 |
| 01:53 ET | 4744 | 5.63 |
| 01:55 ET | 58568 | 5.635 |
| 01:57 ET | 9505 | 5.68 |
| 02:00 ET | 3769 | 5.67 |
| 02:02 ET | 3344 | 5.67 |
| 02:04 ET | 4056 | 5.67 |
| 02:06 ET | 6250 | 5.66 |
| 02:08 ET | 7599 | 5.659 |
| 02:09 ET | 6610 | 5.655 |
| 02:11 ET | 7119 | 5.665 |
| 02:13 ET | 4530 | 5.664 |
| 02:15 ET | 5966 | 5.655 |
| 02:18 ET | 11787 | 5.65 |
| 02:20 ET | 3306 | 5.645 |
| 02:22 ET | 4273 | 5.66 |
| 02:24 ET | 6307 | 5.655 |
| 02:26 ET | 8571 | 5.655 |
| 02:27 ET | 7166 | 5.64 |
| 02:29 ET | 35731 | 5.66 |
| 02:31 ET | 6354 | 5.64 |
| 02:33 ET | 9961 | 5.6501 |
| 02:36 ET | 4072 | 5.655 |
| 02:38 ET | 15801 | 5.655 |
| 02:40 ET | 10122 | 5.6135 |
| 02:42 ET | 8547 | 5.6047 |
| 02:44 ET | 4676 | 5.59 |
| 02:45 ET | 36329 | 5.63 |
| 02:47 ET | 7391 | 5.615 |
| 02:49 ET | 4352 | 5.605 |
| 02:51 ET | 10066 | 5.64 |
| 02:54 ET | 5114 | 5.64 |
| 02:56 ET | 3400 | 5.64 |
| 02:58 ET | 9165 | 5.635 |
| 03:00 ET | 1007 | 5.635 |
| 03:02 ET | 11725 | 5.625 |
| 03:03 ET | 7130 | 5.615 |
| 03:05 ET | 3080 | 5.615 |
| 03:07 ET | 11190 | 5.6 |
| 03:09 ET | 8081 | 5.59 |
| 03:12 ET | 7245 | 5.605 |
| 03:14 ET | 6587 | 5.595 |
| 03:16 ET | 9364 | 5.61 |
| 03:18 ET | 5240 | 5.605 |
| 03:20 ET | 6033 | 5.595 |
| 03:21 ET | 4432 | 5.595 |
| 03:23 ET | 15075 | 5.58 |
| 03:25 ET | 5362 | 5.565 |
| 03:27 ET | 22051 | 5.59 |
| 03:30 ET | 3363 | 5.6 |
| 03:32 ET | 7371 | 5.585 |
| 03:34 ET | 11748 | 5.575 |
| 03:36 ET | 5504 | 5.57 |
| 03:38 ET | 9904 | 5.58 |
| 03:39 ET | 11257 | 5.6 |
| 03:41 ET | 17929 | 5.585 |
| 03:43 ET | 3129 | 5.59 |
| 03:45 ET | 10690 | 5.589 |
| 03:48 ET | 7571 | 5.585 |
| 03:50 ET | 10234 | 5.59 |
| 03:52 ET | 40874 | 5.605 |
| 03:54 ET | 18148 | 5.6175 |
| 03:56 ET | 36809 | 5.62 |
| 03:57 ET | 69430 | 5.625 |
| 03:59 ET | 47607 | 5.64 |
May 8, 2024
DJ Ocular Therapeutix Is Maintained at Buy by HC Wainwright & Co., from 3:29PM ET on Wednesday May 08, 2024 by Dow Jones
3:29PM ET on Wednesday May 08, 2024 by Dow JonesDJ Ocular Therapeutix Is Maintained at Market Outperform by JMP Securities, from 2:18PM ET on Wednesday May 08, 2024 by Dow Jones
2:18PM ET on Wednesday May 08, 2024 by Dow JonesDJ Ocular Therapeutix Is Maintained at Hold by TD Cowen, from 1:08PM ET on Wednesday May 08, 2024 by Dow Jones
1:08PM ET on Wednesday May 08, 2024 by Dow Jones
May 7, 2024
Ocular Therapeutix(TM) Reports First Quarter 2024 Results, from 4:05PM ET on Tuesday May 07, 2024 by Dow Jones
4:05PM ET on Tuesday May 07, 2024 by Dow Jones*DJ Ocular Therapeutix 1Q Loss/Shr 49c >OCUL, from 4:05PM ET on Tuesday May 07, 2024 by Dow Jones
4:05PM ET on Tuesday May 07, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Ocular Therapeutix Inc | 875.8M | -5.2x | --- |
Liquidia Corp | 921.2M | -10.1x | --- |
EyePoint Pharmaceuticals Inc | 629.7M | -6.7x | --- |
Pliant Therapeutics Inc | 833.0M | -4.8x | --- |
Theravance Biopharma Inc | 455.5M | -9.9x | --- |
Petro USA Inc | 1.0B | -31,250.0x | --- |
Company Information
Ocular Therapeutix, Inc. is a biopharmaceutical company. The Company is engaged in the development and commercialization of therapies for wet age-related macular degeneration (wet AMD), diabetic retinopathy, and other diseases and conditions of the eye. Its first commercial drug product, DEXTENZA, is for the treatment of ocular inflammation and pain following ophthalmic surgery and ocular itching associated with allergic conjunctivitis. It is also developing two other clinical-stage assets, OTX-DED (dexamethasone intracanalicular insert) for the short-term treatment of the signs and symptoms of dry eye disease, and OTX-CSI (cyclosporine intracanalicular insert) for the chronic treatment of dry eye disease. It is conducting a pivotal Phase III clinical trial to evaluate AXPAXLI for the treatment of wet AMD. Its clinical portfolio also includes PAXTRAVA, which is in Phase III clinical development for the treatment of primary open-angle glaucoma (OAG) or ocular hypertension (OHT).
Contact Information
- Headquarters
- 15 Crosby DriveBEDFORD, MA, United States 01730
- Phone
- 781-357-4000
- Fax
- 781-357-4001
Executives
- Executive Chairman of the Board, President, Chief Executive Officer
- Pravin Dugel
- Chief Financial Officer
- Donald Notman
- Chief Technical Officer
- Peter Jarrett
- General Counsel
- Philip Strassburger
- Chief Commercial Officer
- Steve Meyers
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $875.8M |
|---|---|
Revenue (TTM) | $59.8M |
Shares Outstanding | 154.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.41 |
EPS | $-1.09 |
Book Value | $0.79 |
P/E Ratio | -5.2x |
Price/Sales (TTM) | 14.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -175.81% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
